BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 29755696)

  • 1. The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.
    Arriaga-Canon C; De La Rosa-Velázquez IA; González-Barrios R; Montiel-Manríquez R; Oliva-Rico D; Jiménez-Trejo F; Cortés-González C; Herrera LA
    Oncotarget; 2018 Apr; 9(29):20872-20890. PubMed ID: 29755696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer.
    Ghiam AF; Vesprini D; Liu SK
    Transl Androl Urol; 2017 Apr; 6(2):326-330. PubMed ID: 28540248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
    Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
    Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNAs Play a Role in the Pathogenesis of Psoriatic Arthritis by Regulating MicroRNAs and Genes Involved in Inflammation and Metabolic Syndrome.
    Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A
    Front Immunol; 2018; 9():1533. PubMed ID: 30061880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer.
    Alahari SV; Eastlack SC; Alahari SK
    Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy.
    Qian Y; Shi L; Luo Z
    Front Med (Lausanne); 2020; 7():612393. PubMed ID: 33330574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Specificity of Disease-Associated lncRNAs: Toward Personalized Medicine.
    Nguyen Q; Carninci P
    Curr Top Microbiol Immunol; 2016; 394():237-58. PubMed ID: 26318140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer.
    Tyagi N; Roy S; Vengadesan K; Gupta D
    Noncoding RNA Res; 2024 Mar; 9(1):66-75. PubMed ID: 38075203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer.
    Taheri M; Badrlou E; Hussen BM; Kashi AH; Ghafouri-Fard S; Baniahmad A
    Front Oncol; 2023; 13():1123101. PubMed ID: 37025585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation.
    Zhao J; Liu Y; Huang G; Cui P; Zhang W; Zhang Y
    Am J Cancer Res; 2015; 5(3):907-27. PubMed ID: 26045977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
    Zheng C; Liu X; Chen L; Xu Z; Shao J
    Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
    Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
    Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.